
Illusio Imaging: Pioneering augmented reality for plastic surgery, offering real-time 3D simulations for confident decisions.
Illusio Imaging was founded with the mission to revolutionize the plastic surgery experience through augmented reality technology. The company's core vision is to empower patients by providing them with real-time 3D simulations of their potential surgical outcomes, thereby enhancing their confidence in making informed decisions. Illusio's primary product is an augmented reality tool that allows surgeons to project virtual images of breast implants onto a patient's body using an iPad, offering a highly personalized and visual consultation process. The market focus is on plastic surgery clinics and patients seeking breast augmentation.
Notable figures associated with Illusio Imaging include its innovative team of technologists and medical professionals who have successfully merged advanced imaging technology with surgical expertise. The company has garnered attention from investors interested in cutting-edge medical technologies. Key achievements include the development and deployment of their real-time 3D simulation tool, which has significantly improved patient satisfaction and decision-making in plastic surgery. Overall, Illusio Imaging has made a substantial impact by enhancing the transparency and confidence in elective surgical procedures through its pioneering use of augmented reality.
Companies similar to Illusio include Imaginostics, Illumicell, Eyeflite and Neurasync.
Illusio was founded in 2014.
Illusio's headquarters is located in San Clemente, CA, US.
Illusio's most recent funding round was for $234.2k (USD) in November 2019.
As of Nov 1, 2019, Illusio has raised a total of $234.2k (USD).
Illusio has 5 employees as of Feb 5, 2024.